Related Experiment Video

Updated: May 21, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

The chronically critically ill patient: pediatric considerations

Stacey L Peterson-Carmichael1, Ira M Cheifetz

  • 1Infant Pulmonary Function Testing Laboratory, the Divisions of Pediatric Critical Care Medicine, Duke University Health System, Durham, North Carolina 27710, USA.

Respiratory Care
|June 6, 2012
PubMed

Insights

A growing population of chronically ill infants and children requires specialized medical and psychosocial support. This review highlights their unique needs and the necessity for increased resources in pediatric chronic illness care.

Area of Science:

  • Pediatric Healthcare
  • Chronic Illness Management
  • Child Development

Background:

  • A distinct population of infants and children with chronic illnesses exists, encompassing those who are critically ill, ventilator-dependent, or medically fragile.
  • These children face heightened risks for physical, developmental, behavioral, and emotional challenges.
  • Their healthcare requirements exceed those typically seen in general pediatric or adult populations.

Purpose of the Study:

  • To define the population of infants and children with chronic healthcare needs.
  • To review the specific management and psychosocial needs of this subgroup.
  • To discuss trends, special requirements, and outcomes for pediatric chronic illness.

Main Methods:

  • Literature review focusing on chronically ill pediatric populations.
  • Analysis of trends in pediatric chronic illness over time.
  • Examination of management strategies and psychosocial support.

Main Results:

  • The number of pediatric patients with chronic illnesses is increasing.
  • This population exhibits unique and complex healthcare needs.
  • Current resources may be insufficient to meet the growing demand.

Conclusions:

  • There is a clear and growing need for specialized care and increased resources for infants and children with chronic illnesses.
  • Addressing the management and psychosocial needs of this group is critical.
  • Further focus on this subgroup is essential for improving outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...